Patents by Inventor John Magnani

John Magnani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170005416
    Abstract: A multi-beam antenna array includes a receiver multi-layer circuit card assembly (CCA) comprising of a first plurality of monolithic microwave integrated circuits (MMICs), a first plurality of radiating elements, and a first plurality of interconnections; a transmitter multi-layer CCA comprising of a second plurality of MMICs, a second plurality of radiating elements, and a second plurality of interconnections; and a single aperture shared by the receiver multi-layer CCA and the transmitter multi-layer CCA, where each of the first and second plurality of MMICs includes mixed analog and digital circuits surface mounted onto said each MMIC.
    Type: Application
    Filed: June 30, 2015
    Publication date: January 5, 2017
    Inventors: Craig D. Gendron, John Magnani, Alan Palevsky, Cameron Thorpe, Darrin T. Jacque, Vincent P. D'Andrea
  • Publication number: 20070054870
    Abstract: Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise particular glycomimetics alone or linked to a member of a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids) or a member of a class of compounds termed BACAs (Benzyl Amino Carboxylic Acids).
    Type: Application
    Filed: September 1, 2006
    Publication date: March 8, 2007
    Applicant: GlycoMimetics, Inc.
    Inventors: John Magnani, John Patton, Arun Sarkar, Sergei Svarovsky, Beat Ernst
  • Publication number: 20070048809
    Abstract: An antigen is shown to be associated with prostate cancer, and is useful for new methods and compositions for diagnosing or treating prostate cancer. This is particularly useful for individuals with prostate cancer who test negative for Prostate Specific Antigen. Additionally, this is useful for distinguishing between benign prostate disease and prostate cancer in a patient diagnosed or presenting with prostate dysfunction.
    Type: Application
    Filed: October 2, 2006
    Publication date: March 1, 2007
    Applicant: GlycoMimetics, Inc.
    Inventor: John Magnani
  • Publication number: 20070037775
    Abstract: Compositions and methods are provided related to Pseudomonas bacteria. The compositions and methods may be used for diagnosis and therapy of medical conditions involving infection with Pseudomonas bacteria. Such infections include Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. A compound useful in the present methods may be used in combination with a therapeutic agent or may be linked to a therapeutic agent. Pseudomonas bacteria may be inhibited by blocking colonization, inhibiting virulence factors, arresting growth or killing the bacteria.
    Type: Application
    Filed: August 8, 2006
    Publication date: February 15, 2007
    Applicant: GlycoMimetics, Inc.
    Inventors: John Magnani, John Patton, Arun Sarkar
  • Publication number: 20060194745
    Abstract: Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids, which include a portion or analogue thereof linked to a carbohydrate or glycomimetic.
    Type: Application
    Filed: April 26, 2006
    Publication date: August 31, 2006
    Applicant: GlycoMimetics, Inc.
    Inventors: John Magnani, John Patton, Leonard Williams
  • Publication number: 20050187171
    Abstract: Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise particular glycomimetics linked to a member of a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids).
    Type: Application
    Filed: November 18, 2004
    Publication date: August 25, 2005
    Applicant: GlycoMimetics, Inc.
    Inventors: John Magnani, John Patton, Arun Sarkar
  • Publication number: 20050164982
    Abstract: Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise a particular glycomimetic linked to a particular BASA (Benzyl Amino Sulfonic Acid).
    Type: Application
    Filed: November 18, 2004
    Publication date: July 28, 2005
    Applicant: GlycoMimetics, Inc.
    Inventors: John Magnani, John Patton